SpiroChem is an Elite Discovery Chemistry Contract Research Organization (CRO) working with clients worldwide from biotechs, pharmaceutical, agrochemical, and life science companies of all sizes.

Our company, operating in Basel, Switzerland, offers unique and innovative solutions covering the entire discovery chemistry value chain:
-	Proprietary Screening Libraries including high-sp3 fragments, covalent fragments and macrocycles
-	SpiroKit as turnkey toolboxes for the medicinal chemistry community to speed up research programs
-	Design & Computational Team for fragment-based drug design (FBDD), structure-based drug design (SBDD) and computational-aided drug design (CADD)
-	Medicinal Chemistry group including experts in enabling technologies (photochemistry, photoredox, electrochemistry, biocatalysis, …) to access target molecule faster and explore uncharted chemical space
-	An Early Development division involved in Route Scouting projects to make the bridge between the medicinal chemistry lab and CDMOs
-	Thanks to two-high potent labs, SpiroChem also supports discovery in the field of ADCs (linker-payload chemistry)


Biotechnology

Chemicals

Pharmaceutical

SpiroChem

Thomas Fessard

Anna Wozniak

Florent Beaufils

Gerhard Müller

The Research and Development team at SpiroChem is dedicated to advancing discovery chemistry through innovative methodologies and technologies. Comprising expert chemists in synthetic organic chemistry, computational design, and novel solutions development, the team collaborates to create proprietary screening libraries, optimize medicinal chemistry processes, and enhance drug design strategies. Their efforts focus on exploring uncharted chemical space and accelerating the transition from research to early development, ultimately delivering tailored solutions for clients in various sectors including biotechnology and pharmaceuticals.

Research and Development

Leadership Team

Research and Development

About

Team members

Other teams at SpiroChem

Leadership Team